177 related articles for article (PubMed ID: 25230243)
1. Markers of the progression of complications in patients with type 2 diabetes: a one-year longitudinal study.
Preciado-Puga MC; Malacara JM; Fajardo-Araujo ME; Wröbel K; Wröbel K; Kornhauser-Araujo C; Garay-Sevilla ME
Exp Clin Endocrinol Diabetes; 2014 Sep; 122(8):484-90. PubMed ID: 25230243
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.
Berg TJ; Snorgaard O; Faber J; Torjesen PA; Hildebrandt P; Mehlsen J; Hanssen KF
Diabetes Care; 1999 Jul; 22(7):1186-90. PubMed ID: 10388987
[TBL] [Abstract][Full Text] [Related]
3. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes.
Aso Y; Inukai T; Tayama K; Takemura Y
Acta Diabetol; 2000; 37(2):87-92. PubMed ID: 11194933
[TBL] [Abstract][Full Text] [Related]
5. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
[TBL] [Abstract][Full Text] [Related]
6. Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.
Yubero-Serrano EM; Woodward M; Poretsky L; Vlassara H; Striker GE;
Clin J Am Soc Nephrol; 2015 May; 10(5):759-66. PubMed ID: 25710801
[TBL] [Abstract][Full Text] [Related]
7. Linking senile dementia to type 2 diabetes: role of oxidative stress markers, C-reactive protein and tumor necrosis factor-α.
Ragy MM; Kamal NN
Neurol Res; 2017 Jul; 39(7):587-595. PubMed ID: 28393627
[TBL] [Abstract][Full Text] [Related]
8. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
Agardh CD; Agardh E; Torffvit O
Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end products (AGEs) and their soluble receptors (sRAGE) as early predictors of reno-vascular complications in patients with uncontrolled type 2 diabetes mellitus.
Farhan SS; Hussain SA
Diabetes Metab Syndr; 2019; 13(4):2457-2461. PubMed ID: 31405660
[TBL] [Abstract][Full Text] [Related]
10. Relationship of serum advanced glycation end products with deterioration of periodontitis in type 2 diabetes patients.
Takeda M; Ojima M; Yoshioka H; Inaba H; Kogo M; Shizukuishi S; Nomura M; Amano A
J Periodontol; 2006 Jan; 77(1):15-20. PubMed ID: 16579698
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycosylation end products (AGEs), insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) in patients with type 2 diabetes mellitus.
Garay-Sevilla ME; Nava LE; Malacara JM; Wróbel K; Wróbel K; Pérez U
Diabetes Metab Res Rev; 2000; 16(2):106-13. PubMed ID: 10751750
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y
J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751
[TBL] [Abstract][Full Text] [Related]
13. The potential impact and diagnostic value of inflammatory markers on diabetic foot progression in type II diabetes mellitus: A case-control study.
Mohamed AA; Elmotaleb Hussein MA; Nabil Hanna I; Japer Nashwan AJ; Saleh M; Abdel Wahed WY; Mohamed Mansour AM; Ezz Al Arab MR; Fawzy N; Sakr Y; Shalby H; AlHussain E; Kamal Darwish M; El-Osaily H; Naguib M; Mohamed AA; Farouk Mohamed W; Hafez W
Med Clin (Barc); 2024 May; 162(9):e33-e39. PubMed ID: 38458959
[TBL] [Abstract][Full Text] [Related]
14. TNF-α and microalbuminuria in patients with type 2 diabetes mellitus.
Lampropoulou IT; Stangou M; Papagianni A; Didangelos T; Iliadis F; Efstratiadis G
J Diabetes Res; 2014; 2014():394206. PubMed ID: 25587544
[TBL] [Abstract][Full Text] [Related]
15. Glycemic control and oxidative stress markers and their relationship with the thioredoxin interacting protein (TXNIP) gene in type 2 diabetic patients.
Andrews Guzmán M; Arredondo Olguín M; Olivares Gronhert M
Nutr Hosp; 2014 Sep; 31(3):1129-33. PubMed ID: 25726203
[TBL] [Abstract][Full Text] [Related]
16. Increased serum levels of advanced glycation end-products and diabetic complications.
Ono Y; Aoki S; Ohnishi K; Yasuda T; Kawano K; Tsukada Y
Diabetes Res Clin Pract; 1998 Aug; 41(2):131-7. PubMed ID: 9789719
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus.
Navarro JF; Mora C; Maca M; Garca J
Am J Kidney Dis; 2003 Jul; 42(1):53-61. PubMed ID: 12830456
[TBL] [Abstract][Full Text] [Related]
18. Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects. Relationship to microvascular complications.
Maejima K; Nakano S; Himeno M; Tsuda S; Makiishi H; Ito T; Nakagawa A; Kigoshi T; Ishibashi T; Nishio M; Uchida K
J Diabetes Complications; 2001; 15(3):135-43. PubMed ID: 11358682
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus.
Berg TJ; Bangstad HJ; Torjesen PA; Osterby R; Bucala R; Hanssen KF
Metabolism; 1997 Jun; 46(6):661-5. PubMed ID: 9186302
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end products in adolescents and young adults with diabetic angiopathy.
Chiarelli F; Catino M; Tumini S; Cipollone F; Mezzetti A; Vanelli M; Verrotti A
Pediatr Nephrol; 2000 Aug; 14(8-9):841-6. PubMed ID: 10955941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
